Literature DB >> 3215884

Urinary free and conjugated catecholamines and metabolites in autistic children.

C Barthelemy1, N Bruneau, J M Cottet-Eymard, J Domenech-Jouve, B Garreau, G Lelord, J P Muh, L Peyrin.   

Abstract

Urinary catecholamines (DA, NE, E) and their main metabolites (HVA, DOPAC, MHPG) were analyzed both as free and conjugates in eight children diagnosed as autistic according to DSM-III criteria and eight normal children. Significant differences appeared for the urinary excretion of both DA and NE and their respective metabolites: Autistic children showed low DA, high HVA, high NE, low MHPG urinary levels. These results are consistent with previous findings on altered catecholamine metabolism in autistic children. They suggest that autistic behaviors might be related to an abnormal functional imbalance among monoamines either at a molecular level or at a system level. Furthermore, they emphasize the special interest of urinary assays in pediatric research.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3215884     DOI: 10.1007/bf02211876

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  31 in total

1.  [Determination of urinary creatinine].

Authors:  M PAGET; M GONTIER; J LIEFOOGHE
Journal:  Ann Biol Clin (Paris)       Date:  1955 Oct-Dec       Impact factor: 0.459

Review 2.  Catecholamine metabolism: basic aspects and clinical significance.

Authors:  I J Kopin
Journal:  Pharmacol Rev       Date:  1985-12       Impact factor: 25.468

3.  Levodopa and levoamphetamine: a crossover study in young schizophrenic children.

Authors:  M Campbell; A M Small; P J Collins; E Friedman; R David; N Genieser
Journal:  Curr Ther Res Clin Exp       Date:  1976-01

4.  Cerebrospinal fluid, plasma, and urinary MHPG in children.

Authors:  J G Young; D J Cohen; M E Kavanagh; H D Landis; B A Shaywitz; J W Maas
Journal:  Life Sci       Date:  1981-06-22       Impact factor: 5.037

5.  Decreased urinary free catecholamines in childhood autism.

Authors:  J G Young; D J Cohen; S L Brown; B K Caparulo
Journal:  J Am Acad Child Psychiatry       Date:  1978

6.  Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.

Authors:  L T Anderson; M Campbell; D M Grega; R Perry; A M Small; W H Green
Journal:  Am J Psychiatry       Date:  1984-10       Impact factor: 18.112

7.  6-Hydroxydopamine lesions of dopaminergic A10 neurons. Long-term effects on the urinary excretion of free and conjugated catecholamines and their metabolites in the rat.

Authors:  L Peyrin; H Simon; J M Cottet-Emard; N Bruneau; M Le Moal
Journal:  Brain Res       Date:  1982-03-11       Impact factor: 3.252

8.  Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.

Authors:  B A Shaywitz; D J Cohen; J F Leckman; J G Young; M B Bowers
Journal:  Dev Med Child Neurol       Date:  1980-12       Impact factor: 5.449

9.  Decreased 24-hour urinary MHPG in childhood autism.

Authors:  J G Young; D J Cohen; B K Caparulo; S L Brown; J W Maas
Journal:  Am J Psychiatry       Date:  1979-08       Impact factor: 18.112

10.  Free and conjugated 3-methoxy-4-hydroxyphenylglycol in human urine: peripheral origin of glucuronide.

Authors:  L Peyrin; J M Pequignot
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more
  13 in total

1.  Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder.

Authors:  Christa J Anderson; John Colombo; Kathryn E Unruh
Journal:  Dev Psychobiol       Date:  2012-05-29       Impact factor: 3.038

2.  Intelligence patterns among children with high-functioning autism, phenylketonuria, and childhood head injury.

Authors:  M Dennis; L Lockyer; A L Lazenby; R E Donnelly; M Wilkinson; W Schoonheyt
Journal:  J Autism Dev Disord       Date:  1999-02

3.  Goal directed locomotion and balance control in autistic children.

Authors:  S Vernazza-Martin; N Martin; A Vernazza; A Lepellec-Muller; M Rufo; J Massion; C Assaiante
Journal:  J Autism Dev Disord       Date:  2005-02

4.  Plasma amino acid levels in children with autism and their families.

Authors:  Sarah Aldred; Kieran M Moore; Michael Fitzgerald; Rosemary H Waring
Journal:  J Autism Dev Disord       Date:  2003-02

5.  Investigation of whole blood and urine monoamines in autism.

Authors:  Josiane Hérault; Joëlle Martineau; Anne Perrot-Beaugerie; Jacqueline Jouve; Hervé Tournade; Catherine Barthelemy; Gilbert Lelord; Jean-Pierre Muh
Journal:  Eur Child Adolesc Psychiatry       Date:  1993-10       Impact factor: 4.785

6.  The Behavioral Summarized Evaluation: validity and reliability of a scale for the assessment of autistic behaviors.

Authors:  C Barthelemy; J L Adrien; P Tanguay; B Garreau; J Fermanian; S Roux; D Sauvage; G Lelord
Journal:  J Autism Dev Disord       Date:  1990-06

7.  Association of ADHD, tics, and anxiety with dopamine transporter (DAT1) genotype in autism spectrum disorder.

Authors:  Kenneth D Gadow; Jasmin Roohi; Carla J DeVincent; Eli Hatchwell
Journal:  J Child Psychol Psychiatry       Date:  2008-12       Impact factor: 8.982

8.  Urinary dopamine metabolites as indicators of the responsiveness to fenfluramine treatment in children with autistic behavior.

Authors:  C Barthelemy; N Bruneau; J Jouve; J Martineau; J P Muh; G Lelord
Journal:  J Autism Dev Disord       Date:  1989-06

9.  Quantified multidimensional assessment of autism and other pervasive developmental disorders. Application for bioclinical research.

Authors:  L Hameury; S Roux; C Barthélémy; J L Adrien; H Desombre; D Sauvage; B Garreau; G Lelord
Journal:  Eur Child Adolesc Psychiatry       Date:  1995-04       Impact factor: 4.785

Review 10.  The Role of the Noradrenergic System in Autism Spectrum Disorders, Implications for Treatment.

Authors:  David Q Beversdorf
Journal:  Semin Pediatr Neurol       Date:  2020-06-24       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.